Neuroprotective effects of creatine (Q37859313)

24 August 2017

1 reference

title

Neuroprotective effects of creatine (English)

1 reference

24 August 2017

1

M Flint Beal

1 reference

24 August 2017

30 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

40

1 reference

24 August 2017

1305-1313

1 reference

24 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00726-011-0851-0

24 August 2017

0 references

cites work

Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Plasticity of skeletal muscle mitochondria in response to contractile activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Oxidative modification of creatine kinase BB in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Functions and effects of creatine in the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Mitochondria, free radicals, and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Experimental models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Oxidative stress in Alzheimer disease: a possibility for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Oxidative damage in Huntington's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Impaired PGC-1alpha function in muscle in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Caspase activation precedes and leads to tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Focally elevated creatine detected in amyloid precursor protein (APP) transgenic mice and Alzheimer disease brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Mitochondria and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Riluzole serum concentrations in patients with ALS: associations with side effects and symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Mitochondrial dysfunction and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Stabilization of ubiquitous mitochondrial creatine kinase preprotein by APP family proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Creatine and cyclocreatine attenuate MPTP neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

PGC-1alpha, a new therapeutic target in Huntington's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Effect of short-term creatine supplementation on renal responses in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Adverse effects of creatine supplementation: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

A clinical trial of creatine in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

The cloning and expression of a human creatine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

The potential benefits of creatine and conjugated linoleic acid as adjuncts to resistance training in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Creatine kinase in non-muscle tissues and cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

Protective Effect of the Energy Precursor Creatine Against Toxicity of Glutamate and β-Amyloid in Rat Hippocampal Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00726-011-0851-0

10.1007/S00726-011-0851-0

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21448659